Search

1 to 10 of 265
Sort by

Event
Immuno-Oncology Young Investigators' Forum

Presented by The University of Texas MD Anderson Cancer Center and Creative Educational Concepts, Inc. (CEC) in collaboration with the Society for Immunotherapy of Cancer. This program is ideally suited for North American-based junior faculty, fellows, and postdoctoral researchers (MDs, DOs,...

 04-16-2020 08:00 - 04-18-2020 20:00 CT
 Houston TX


Library Entry
Sarcosine promotes trafficking of dendritic cells and improves efficacy of anti-tumor dendritic cell vaccines via CXC chemokine family signaling

Dendritic cell (DC) vaccine efficacy is directly related to the efficiency of DC migration to the lymph node after delivery to the patient. The authors discovered that a naturally occurring metabolite, sarcosine, increases DC migration in human and murine cells resulting in significantly...


Library Entry
Blood-derived dendritic cell vaccinations induce immune responses that correlate with clinical outcome in patients with chemo-naive castration-resistant prostate cancer

Clinical benefit of cellular immunotherapy has been shown in patients with castration-resistant prostate cancer (CRPC) . The authors investigated the immunological response and clinical outcome of vaccination with blood-derived CD1c + myeloid dendritic cells (mDCs; cDC2) and plasmacytoid...







Library Entry
The Global Promise of Cancer Immunotherapy: Patient Webinar

The Society for Immunotherapy of Cancer (SITC) , in collaboration with the European Cancer Patient Coalition (ECPC) , hosted a patient-focused webinar on the promise of immunotherapy to treat cancer on January 30 th , 2018. Through the Global Promise of Cancer Immunotherapy Webinar, patients,...

The Global Promise of Cancer Immunotherapy.mp4